OPK Stock Analysis: Buy, Sell, or Hold?
OPK - Opko Health Inc.
$1.52
-0.01 (-0.65%)
▼
5d:
+0.66%
30d:
+8.57%
90d:
+34.51%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 30, 2026
26d
Smart Money Accumulation
None View Scanner →
Strength: 5.0/10
Get Alerted When OPK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OPK shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: OPK shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: OPK is currently trading at $1.52, which is considered extended relative to its 30-day fair value range of $1.38 to $1.50.
Technical Outlook: Technically, OPK is in a strong uptrend. Immediate support is located at $1.35, while resistance sits at $1.61.
Market Sentiment: OPK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.38 (+187.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OPK is in a strong uptrend. Immediate support is located at $1.35, while resistance sits at $1.61.
Market Sentiment: OPK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.38 (+187.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.38 -
$1.50
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 187.8% below Wall St target ($4.38)
Trading Range Analysis
30-Day Trading Range
$1.38 -
$1.50
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.36
Resistance Level
$1.61
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.75
Wall Street Target
$4.38
(+187.8%)
Revenue Growth (YoY)
-17.2%
Earnings Growth (YoY)
-12.6%
Profit Margin
-36.6%
Share & Embed Analysis
Last updated: July 02, 2026 10:42 PM ET
Data refreshes hourly during market hours. Next update: 11:42 PM
Data refreshes hourly during market hours. Next update: 11:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPK showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
John A Paganelli
BUY
10000 shares
2026-03-20
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 64 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$144 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
